UPC News

In a turbulent week for the IPO market, 17 IPOs and 20 SPACs went public, and one company postponed, defense contractor Leonardo DRS (DRS). While returns cooled off, with just over half of the week’s IPOs finishing below issue, there were a few bright spots, led by biotechs Design Therapeutics (DSGN) and Ikena Oncology...read more

Universe Pharmaceuticals, a Chinese pharmaceutical specializing in traditional Chinese medicine derivatives, raised $25 million by offering 5 million shares at $5, the low end of the range of $5 to $7. At pricing, the company commands a market value of $105 million. The company manufactures, markets, and distributes traditional Chinese medicine derivative (TCMD) products...read more

Updated Monday, 3/15. The IPO market starts to pick back up with 10 IPOs scheduled to raise $2.5 billion in the week ahead. Chinese IoT platform developer Tuya (TUYA) plans to raise $806 million at a $10.4 billion market cap. Tuya’s platform offers PaaS and SaaS to over 5,000 customers for the development, management, and monetization of...read more

Universe Pharmaceuticals, a Chinese pharmaceutical specializing in traditional Chinese medicine derivatives, launched its IPO on Tuesday. The Jiangxi, China-based company plans to raise $30 million by offering 5 million shares at a price range of $5 to $7. At the midpoint of the proposed range, Universe Pharmaceuticals would command a market value of $126 million. The...read more